| 1 |
34734507 | The Role of In Vitro Detection of Drug-Specific Mediator-Releasing Cells to Diagnose Different Phenotypes of Severe Cutaneous Adverse Reactions. | 2021 Nov |
1 |
| 2 |
31160756 | Spatial distribution of IL4 controls iNKT cell-DC crosstalk in tumors. | 2020 May |
2 |
| 3 |
32450553 | Natural Killer T Cells Are Numerically and Functionally Deficient in Patients with Trauma. | 2020 |
1 |
| 4 |
29975662 | Sphingolipids in early viral replication and innate immune activation. | 2018 Sep 25 |
1 |
| 5 |
28193627 | Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial. | 2017 Jul 15 |
1 |
| 6 |
26852856 | In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide-Loaded Liposomes and Interleukin-12. | 2016 Jan |
2 |
| 7 |
26862702 | Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells. | 2016 Feb 9 |
1 |
| 8 |
25499027 | Chronic alcohol consumption enhances iNKT cell maturation and activation. | 2015 Jan 15 |
1 |
| 9 |
26121617 | Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells. | 2015 |
1 |
| 10 |
26215444 | Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection. | 2015 Oct |
1 |
| 11 |
22386518 | Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses. | 2012 May 10 |
1 |
| 12 |
22534863 | Accumulation of activated invariant natural killer T cells in the tumor microenvironment after α-galactosylceramide-pulsed antigen presenting cells. | 2012 Oct |
1 |
| 13 |
22581860 | Contact-dependent interference with invariant NKT cell activation by herpes simplex virus-infected cells. | 2012 Jun 15 |
2 |
| 14 |
23028326 | Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection. | 2012 Sep |
1 |
| 15 |
21245578 | Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity. | 2011 Feb |
1 |
| 16 |
21283989 | Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells. | 2011 Jul |
2 |
| 17 |
22195564 | Glycolipids that elicit IFN-γ-biased responses from natural killer T cells. | 2011 Dec 23 |
1 |
| 18 |
20410589 | Invariant Valpha14 natural killer T cell activation by edible mushroom acidic glycosphingolipids. | 2010 |
2 |
| 19 |
20508728 | Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell. | 2010 |
1 |
| 20 |
20804502 | A set of genes associated with the interferon-γ response of lung cancer patients undergoing α-galactosylceramide-pulsed dendritic cell therapy. | 2010 Nov |
1 |
| 21 |
20942806 | Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma. | 2010 Dec |
1 |
| 22 |
18178816 | Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. | 2008 Jan 15 |
1 |
| 23 |
18350544 | Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells. | 2008 Apr |
2 |
| 24 |
18706662 | T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired. | 2008 Dec 15 |
1 |
| 25 |
17266209 | Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer. | 2007 Feb 8 |
1 |
| 26 |
17277112 | Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes. | 2007 Feb 15 |
1 |
| 27 |
16505600 | [iNKT cells, a friend or a foe for autoimmune disease and allergy?]. | 2006 Feb |
2 |
| 28 |
17015708 | Expression of CD1d molecules by human schwann cells and potential interactions with immunoregulatory invariant NK T cells. | 2006 Oct 15 |
1 |
| 29 |
15778340 | Cutting edge: IFN-gamma signaling to macrophages is required for optimal Valpha14i NK T/NK cell cross-talk. | 2005 Apr 1 |
1 |
| 30 |
15922476 | Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice. | 2005 Oct |
2 |
| 31 |
16186183 | Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. | 2005 Oct 3 |
1 |
| 32 |
14734606 | Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis. | 2004 Feb |
1 |
| 33 |
14734609 | Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. | 2004 Feb |
1 |
| 34 |
15259008 | Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. | 2004 Aug |
1 |
| 35 |
15574787 | Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. | 2004 Dec 1 |
1 |
| 36 |
12902477 | NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. | 2003 Aug 15 |
2 |
| 37 |
12962036 | [Treatment for multiple sclerosis with a synthetic glycolipid]. | 2003 Aug |
1 |
| 38 |
11830474 | Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. | 2002 Feb 15 |
1 |
| 39 |
12444115 | Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro. | 2002 Dec 1 |
1 |
| 40 |
11164462 | Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. | 2000 Dec 20 |
1 |